Ghost Tree Capital, LLC Allakos Inc. Transaction History

Ghost Tree Capital, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 16, 2022	SELL	$8.55 - $111.89 $726,750 - $9.51 Million	-85,000 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$76.53 - $110.43 $6.51 Million - $9.39 Million	85,000 New	85,000 $9 Million
Q3 2019 Nov 14, 2019	SELL	$31.0 - $89.73 $325,500 - $942,165	-10,500 Closed	0 $0
Q2 2019 Aug 14, 2019	BUY	$36.0 - $44.73 $378,000 - $469,664	10,500 New	10,500 $455,000
Q4 2018 Feb 14, 2019	SELL	$31.59 - $62.65 $2.37 Million - $4.7 Million	-75,000 Closed	0 $0
Q3 2018 Nov 14, 2018	BUY	$31.25 - $47.64 $2.34 Million - $3.57 Million	75,000 New	75,000 $3.37 Million

64.7M

47.1K

Ticker ALLK
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 84,726,096
Market Cap $81.3M
Description
Allakos Inc., a clinical stage biopharmaceutical company, develops therapeutics that target immunomodulatory receptors present on immune effector cells in allergy, inflammatory, and proliferative diseases. The company's lead monoclonal antibody is lirentelimab (AK002), which is in a Phase III study for the treatment of eosinophilic gastritis and...

Get notified when there are updates to the investment portfolio of Ghost Tree Capital, LLC, based on Form 13F filings with the SEC.

Stay updated on Ghost Tree Capital, LLC with notifications on news.